Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017. (Q51675909)
Jump to navigation
Jump to search
scientific article published in November 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017. |
scientific article published in November 2008 |
Statements
1 reference
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017. (English)
1 reference
Hossein Borghaei
1 reference
Corey J Langer
1 reference
Michael Millenson
1 reference
Karen J Ruth
1 reference
Samuel Litwin
1 reference
Holly Tuttle
1 reference
Judie Sylvester Seldomridge
1 reference
Marc Rovito
1 reference
David Mintzer
1 reference
Roger Cohen
1 reference
Joseph Treat
1 reference
1 November 2008
1 reference
3
1 reference
1286-1292
1 reference
11
1 reference
Identifiers
1 reference